Chembio Diagnostics Investor Relations Material

Chembio Diagnostics Inc. is a biotechnology company specializing in the development, manufacturing, and commercialization of point-of-care diagnostic products. The company focuses on delivering diagnostic solutions for infectious diseases and other medical conditions. Its offerings utilize proprietary technologies to provide rapid, accurate results in healthcare settings, aiming to support clinical decision-making and public health efforts. Its portfolio encompasses diagnostic assays, devices, and related components tailored to specific testing requirements. Chembio Diagnostics Inc. is headquartered in Hauppauge, New York, and its shares are listed on the NASDAQ.